Information Journal Paper
APA:
CopyNAHTA, R., & YU, D.. (2006). MECHANISMS OF DISEASE: UNDERSTANDING RESISTANCE TO HER2-TARGETED THERAPY IN HUMAN BREAST CANCER. NATURE CLINICAL PRACTICE ONCOLOGY, 3(5), 269-280. SID. https://sid.ir/paper/638811/en
Vancouver:
CopyNAHTA R., YU D.. MECHANISMS OF DISEASE: UNDERSTANDING RESISTANCE TO HER2-TARGETED THERAPY IN HUMAN BREAST CANCER. NATURE CLINICAL PRACTICE ONCOLOGY[Internet]. 2006;3(5):269-280. Available from: https://sid.ir/paper/638811/en
IEEE:
CopyR. NAHTA, and D. YU, “MECHANISMS OF DISEASE: UNDERSTANDING RESISTANCE TO HER2-TARGETED THERAPY IN HUMAN BREAST CANCER,” NATURE CLINICAL PRACTICE ONCOLOGY, vol. 3, no. 5, pp. 269–280, 2006, [Online]. Available: https://sid.ir/paper/638811/en